Does REGADENOSON Cause Incorrect product administration duration? 79 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 79 reports of Incorrect product administration duration have been filed in association with REGADENOSON (Regadenoson). This represents 2.6% of all adverse event reports for REGADENOSON.
79
Reports of Incorrect product administration duration with REGADENOSON
2.6%
of all REGADENOSON reports
0
Deaths
12
Hospitalizations
How Dangerous Is Incorrect product administration duration From REGADENOSON?
Of the 79 reports, 12 (15.2%) required hospitalization, and 3 (3.8%) were considered life-threatening.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REGADENOSON. However, 79 reports have been filed with the FAERS database.
What Other Side Effects Does REGADENOSON Cause?
Nausea (311)
Dyspnoea (271)
Seizure (247)
Vomiting (233)
Injection site extravasation (226)
Hypotension (200)
Headache (190)
Cardiac arrest (183)
Dizziness (160)
Blood pressure decreased (143)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which REGADENOSON Alternatives Have Lower Incorrect product administration duration Risk?
REGADENOSON vs REGORAFENIB
REGADENOSON vs REGORAFENIB\REGORAFENIB
REGADENOSON vs RELATLIMAB
REGADENOSON vs RELPAX
REGADENOSON vs RELUGOLIX